SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Korablina Elena A
(Last) (First) (Middle)
383 MADISON AVENUE
(Street)
NEW YORK NY 10179-0001
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
JPMORGAN CHASE & CO [ JPM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Corporate Controller
3. Date of Earliest Transaction (Month/Day/Year)
01/13/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/13/2024 M 2,940 A $0(1) 27,591 D
Common Stock 01/13/2024 M 2,747 A $0(1) 30,338 D
Common Stock 01/13/2024 M 1,932 A $0(1) 32,270 D
Common Stock 01/13/2024 F 3,957 D $172.605 28,313 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 01/13/2024 M 2,747 (2) 01/13/2024 Common Stock 2,747 $0.0000 0.0000 D
Restricted Stock Units (1) 01/13/2024 M 1,932 (3) 01/13/2025 Common Stock 1,932 $0.0000 1,932 D
Restricted Stock Units (1) 01/13/2024 M 2,940 (4) 01/13/2026 Common Stock 2,940 $0.0000 17,458 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of JPMC common stock.
2. Restricted stock units grant of 3,417 shares vests as follows: 1,139 shares on January 13, 2022, 1,139 shares on January 13, 2023, and 1,139 shares on January 13, 2024. As Identified Staff (employees who are material risk-takers identified under U.K. and/or European Union standards) at the time of grant, the shares resulting from vesting must be held for 6 months from vesting date. Restricted stock units grant of 4,822 shares will vest as follows: 1,607 shares on January 13, 2022, 1,607 shares on January 13, 2023, and 1,608 shares on January 13, 2024. As Identified Staff at the time of grant, the shares resulting from vesting must be held 12 months from vesting date.
3. Restricted stock units grant of 6,310 shares vests as follows: 1,262 shares on January 13, 2021, 1,262 shares on January 13, 2022, 1,262 shares on January 13, 2023, 1,262 shares on January 13, 2024, and 1,262 shares on January 13, 2025. As Identified Staff at the time of grant, shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 1,340 shares vest as follows: 670 shares on January 13, 2024, and 670 shares on January 13, 2025.
4. Restricted stock units grant of 5,600 shares vests as follows: 1,400 shares on January 13, 2023, 1,400 shares on January 13, 2024, 1,400 shares on January 13, 2025, and 1,400 shares on January 13, 2026. As Identified Staff for a portion of year to which the grant relates, the shares resulting from vesting must be held for 12 months from vesting date; restricted stock grant of 7,702 shares vests as follows: 1,540 shares on January 13, 2022, 1,540 shares on January 13, 2023, 1,540 shares on January 13, 2024, 1,541 shares on January 13, 2025, and 1,541 shares on January 13, 2026. As Identified Staff at the time of grant, the shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 11,576 shares vests 50% on January 13, 2025 and January 13, 2026.
/s/ Holly Youngwood under POA 01/16/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.